Seoul, South Korea

Cassian Yee

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Innovative Approaches by Inventor Cassian Yee in Cancer Treatment**

Introduction

Cassian Yee is a distinguished inventor based in Seoul, South Korea, who has made significant contributions to the fields of immunology and cancer treatment. With his innovative approach, he aims to enhance the efficacy of natural killer (NK) cell therapies, providing new avenues for cancer prevention and treatment.

Latest Patents

Cassian Yee holds a notable patent titled "Method for the induction and expansion of natural killer cells derived from peripheral blood mononuclear cells." This invention outlines a method that involves co-culturing irradiated Jurkat cells and Epstein-Barr virus transformed lymphocyte continuous line (EBV-LCL) cells with cytokines and peripheral blood mononuclear cells. His method enables the induction and proliferation of NK cells from a small amount of mononuclear cells without the need for high-cost equipment or expensive cytokines. This advancement promises to significantly improve the efficiency and effectiveness of cancer treatments utilizing NK cells.

Career Highlights

Yee is affiliated with Nkmax Co., Ltd., where his expertise and innovations play a crucial role in the development of novel cancer therapies. His research focuses on harnessing the power of the immune system to fight cancer, positioning him as a key figure in ongoing cancer research and therapy development.

Collaborations

Throughout his career, Cassian Yee has worked alongside talented colleagues such as Kyung Mi Lee and Seon Ah Lim. These collaborations contribute to a vibrant research environment that fosters innovation and the exploration of novel therapeutic strategies for cancer treatment.

Conclusion

Cassian Yee's patent for the induction and expansion of natural killer cells marks a significant step forward in cancer therapy. His work at Nkmax Co., Ltd. and collaborations with dedicated professionals underline his commitment to advancing medical science and improving patient outcomes. As the field of immunotherapy continues to evolve, contributions from inventors like Yee are crucial to unlocking new and effective treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…